Regular Practice of Ejaculation May Reduce Risk of Prostate Cancer

If a male ejaculates at least once a day, the chances of exposure to prostate cancer risk are very low.

Men can reduce the risk of developing prostate cancer by daily ejaculation, revealed a new study.

Experts at the Harvard Medical School and Brigham and Women Hospital have conducted a study on male participants who were observed for several years. They found that if a man ejaculates at least once a day, the chances of exposure to prostate cancer are very low.

Middle-Aged Women More Likely to Experience a Sleep Orgasm
Sleep orgasms can occur a couple of times a week, with or without the help of self-pleasure. It occurs primarily in women aged 40-50.

‘Prostate cancer is the most common cancer after skin cancer among men. Almost two million people in the world are currently suffering from the disease.’

The study showed that men who ejaculated more than 21 times a month had a 22 percent lower risk of getting the disease.

Jennifer Rider of Harvard Medical School and Brigham and Women’s Hospital, said, “While these data are the most compelling to date on the potential benefit of ejaculation on prostate cancer development, they are observational data and should be interpreted somewhat cautiously. At the same time, given the lack of modifiable risk factors for prostate cancer, the results of this study are particularly encouraging.”

Source-Medindia

Best Time for Sex? 5.48 A.m. As Couples are Most Likely to Reach Orgasm In the Morning
Testosterone levels in men and women are highest in the morning, the energy levels of both are highest, too - a prerequisite for making love, say researchers.

Prostate Cancer Discovery Could Lead To Better Treatments
A cellular signaling pathway activated by radiation to halt cell division and repair DNA damage also controls cells' sensitivity to androgen, which is needed for cancer cells to grow.

Scientists Discover New �Suicide Gene� Therapy To Kill Prostate Cancer Cells
The new suicide gene therapy technique helps patients’ body to kill prostate cancer cells, which is a safe and effective way to fight against the disease.